The 2018 China’s Independent Innovation Brand Value list was released, and the brand value of Jilin Aodong was 18.63 billion yuan. Jilin Aodong was formerly the state-owned Yanbian Dunhua Luchang established in 1957, and the Aodong Pharmaceutical Factory was established in 1981 , was restructured into Jilin Aodong Pharmaceutical Group Co., Ltd. in March 1993 with the approval of the Provincial Restructuring Commission, and was listed on the Shenzhen Stock Exchange on October 28, 1996.

The company's industry is pharmaceutical manufacturing, mainly. Engaged in the research and development, manufacturing and sales of Chinese patent medicines and biochemical drugs, while actively expanding into health food, food, breeding, planting and other fields, it has gradually developed into a holding company based on the pharmaceutical industry and developing rapidly with the "industry + finance" two-wheel drive model. A listed company in the Group. The company's asset scale, quality and efficiency are among the best in the industry. The company is in a weak cyclical industry. During the reporting period, the company continued to strengthen its innovation-driven strategic layout and continuously increased investment in research and development, making the company's products more competitive. Market competitiveness has been further strengthened, and operational efficiency and profitability have been continuously improved.

Brand advantage: The "Aodongjitu" trademark is a well-known trademark in China. It is the result of the company's brand establishment and brand expansion over the past 30 years since its establishment as a pharmaceutical factory. , a valuable intangible asset formed after brand maintenance. As a symbol of the enterprise and a guarantee of quality, the "Aodong" brand has been selected into the "China's 500 Most Valuable Brands" released by the World Brand Lab for 14 consecutive years. With a value of 8.009 billion yuan, it represents reputation, quality and responsibility. At the same time, the company's products have won widespread recognition from all walks of life and achieved good reputation and reputation. Quality advantage: The company insists on quality first and continuously promotes quality reforms to enhance quality advantages. The company has a national-level enterprise technology center and a national-level postdoctoral research station. Its pharmaceutical subsidiaries have successively passed the 2010 version of GMP certification, seizing development opportunities and winning strategies. Proactively. The company has formulated internal control standards that are higher than the national legal standards, established the concept of "quality is the life of the enterprise", adheres to the spirit of "craftsman", strictly manages product quality, improves drug quality, strives for product excellence, and ensures that every drug , every medicine is safe, reliable and reliable. Yanbian Pharmaceutical has won the title of National Industrial Enterprise Quality Benchmark and Jilin Provincial Quality Award; Yanji Pharmaceutical has won the Jilin Provincial Quality Award, and Taonan Pharmaceutical has won the Jilin Provincial Quality Award. p>

Capital advantages: The company has established an "industrial finance" two-wheel-driven growth model, using its financial advantages to support the development of the real industry. Based on its main business of medicine, the company timely invests in the equity of GF Securities and conducts market value management, becoming the third company of GF Securities. A major shareholder, it made equity investment in First Pharmaceutical and became its second largest shareholder. It participated in the non-public offering of Yatai Group and became its sixth largest shareholder. The company's development path of "integration of industry and finance" has promoted the rapid development of the pharmaceutical industry.